Efficacy of NVX-CoV2373 Covid-19 vaccine against the B. 1.351 variant V Shinde, S Bhikha, Z Hoosain, M Archary, Q Bhorat, L Fairlie, U Lalloo, ... New England Journal of Medicine 384 (20), 1899-1909, 2021 | 728 | 2021 |
Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study W Jassat, C Cohen, S Tempia, M Masha, S Goldstein, T Kufa, ... The Lancet HIV 8 (9), e554-e567, 2021 | 186 | 2021 |
Systematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the Cresting Wave BC Zanoni, M Archary, S Buchan, IT Katz, JE Haberer BMJ global health 1 (3), e000004, 2016 | 170 | 2016 |
Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study W Jassat, C Mudara, L Ozougwu, S Tempia, L Blumberg, MA Davies, ... The Lancet Global Health 9 (9), e1216-e1225, 2021 | 168 | 2021 |
Dolutegravir as first-or second-line treatment for HIV-1 infection in children A Turkova, E White, HA Mujuru, AR Kekitiinwa, CM Kityo, A Violari, ... New England Journal of Medicine 385 (27), 2531-2543, 2021 | 96 | 2021 |
Nevirapine-versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 randomized trial L Barlow-Mosha, K Angelidou, J Lindsey, M Archary, M Cotton, S Dittmer, ... Clinical Infectious Diseases 63 (8), 1113-1121, 2016 | 64 | 2016 |
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages JN Bhiman, SI Richardson, BE Lambson, P Kgagudi, N Mzindle, ... Scientific reports 13 (1), 1222, 2023 | 54 | 2023 |
Malnutrition in HIV-infected children is an indicator of severe disease with an impaired response to antiretroviral therapy M Muenchhoff, M Healy, R Singh, J Roider, A Groll, C Kindra, T Sibaya, ... AIDS research and human retroviruses 34 (1), 46-55, 2018 | 52 | 2018 |
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A … SA Madhi, D Moodley, S Hanley, M Archary, Z Hoosain, U Lalloo, C Louw, ... The Lancet HIV 9 (5), e309-e322, 2022 | 50 | 2022 |
Long-acting antiretrovirals and HIV treatment adherence JB Nachega, KK Scarsi, M Gandhi, RK Scott, LM Mofenson, M Archary, ... The Lancet HIV 10 (5), e332-e342, 2023 | 42 | 2023 |
An isolated outbreak of diphtheria in South Africa, 2015 S Mahomed, M Archary, P Mutevedzi, Y Mahabeer, P Govender, ... Epidemiology & Infection 145 (10), 2100-2108, 2017 | 41 | 2017 |
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list M Penazzato, CL Townsend, N Rakhmanina, Y Cheng, M Archary, ... The Lancet HIV 6 (9), e623-e631, 2019 | 39 | 2019 |
Transition from pediatric to adult care for adolescents living with HIV in South Africa: A natural experiment and survival analysis BC Zanoni, M Archary, T Sibaya, N Musinguzi, JE Haberer PLoS One 15 (10), e0240918, 2020 | 37 | 2020 |
High-frequency failure of combination antiretroviral therapy in paediatric HIV infection is associated with unmet maternal needs causing maternal non-adherence JR Millar, N Bengu, R Fillis, K Sprenger, V Ntlantsana, VA Vieira, ... EClinicalMedicine 22, 2020 | 36 | 2020 |
Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps … S Nachman, CL Townsend, EJ Abrams, M Archary, E Capparelli, ... The Lancet HIV 6 (8), e552-e558, 2019 | 36 | 2019 |
Systematic review of mHealth interventions for adolescent and young adult HIV prevention and the adolescent HIV continuum of care in low to middle income countries M Goldstein, M Archary, J Adong, JE Haberer, LM Kuhns, A Kurth, ... AIDS and Behavior 27 (Suppl 1), 94-115, 2023 | 35 | 2023 |
Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review TG Jacobs, EM Svensson, V Musiime, P Rojo, KE Dooley, H McIlleron, ... Journal of Antimicrobial Chemotherapy 75 (12), 3433-3457, 2020 | 34 | 2020 |
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested … CL Moore, A Turkova, H Mujuru, A Kekitiinwa, A Lugemwa, CM Kityo, ... BMC infectious diseases 21, 1-14, 2021 | 33 | 2021 |
Molecular characterization of Corynebacterium diphtheriae outbreak isolates, South Africa, March–June 2015 M du Plessis, N Wolter, M Allam, L de Gouveia, F Moosa, G Ntshoe, ... Emerging Infectious Diseases 23 (8), 1308, 2017 | 33 | 2017 |
Disclosure, social support, and mental health are modifiable factors affecting engagement in care of perinatally-HIV infected adolescents: a qualitative dyadic analysis BC Zanoni, M Archary, T Subramony, T Sibaya, C Psaros, JE Haberer AIDS and Behavior 25, 237-248, 2021 | 31 | 2021 |